Annals of Emergency Medicine
Volume 43, Issue 3 , Pages 315-317 , March 2004

Tetanus prophylaxis in the emergency department

  • Martha H Roper, MD, MPH

      Affiliations

    • Corresponding Author InformationAddress for correspondence: Martha H. Roper, MD, MPH, Bacterial Vaccine Preventable Disease Branch, National Immunization Program, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop E-61, Atlanta, GA 30333; 404-639-8741, fax 404-639-2483

References 

    References
  1. Pascual FB, McGinley EL, Zanardi LR, et al.  Tetanus surveillance—United States, 1998-2000. MMWR. 2003;52(No. SS-3):1–8
  2. Bardenheier B, Prevots DR, Khetsuriani N, et al.  Tetanus surveillance—United States, 1995-1997. MMWR. 1999;47(No. SS-2):1–13
  3. Izurieta HS, Sutter RW, Strebel PM, et al.  Tetanus surveillance—United States, 1991-1994. MMWR. 1997;46(No. SS-2):15–25
  4. Talan DA, Abrahamian FM, Moran GJ, et al.  Tetanus immunity and physician compliance with tetanus prophylaxis practices among emergency department patients presenting with wounds. Ann Emerg Med. 2004;43:305–314
  5. Advisory Committee on Immunization Practices . Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures—recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR. 1991;40(No. RR-10):1–38
  6. Centers for Disease Control and Prevention . Tetanus—Puerto Rico, 2002. MMWR. 2002;51:613–615
  7. McQuillan GM, Kruszon-Moran D, Deforest A, et al.  Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med. 2002;136:660–666
  8. Gergen PJ, McQuillan GM, Kiely M, et al.  A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med. 1995;332:761–766
  9. Wassilak SGF, Roper MH, Murphy TV, et al.  Tetanus toxoid. In:  Plotkin SA,  Orenstein WA editor. Vaccines. 4th ed.. Philadelphia, PA: WB Saunders; 2004;p. 745–781
  10. Galazka AM. The immunologic basis for immunization: tetanus (WHO/EPI/GEN/13.13). Geneva, Switzerland: World Health Organization; 1993; Available at: http://whqlibdoc.who.int/hq/1993/WHO_EPI_GEN_93.13_mod3.pdf. Accessed October 22, 2003.
  11. Singleton JA, Greby SM, Wooten KG, et al.  Influenza, pneumococcal, and tetanus toxoid vaccination of adults—United States, 1993-1997. MMWR. 2000;49(No. SS-9):39–52
  12. Centers for Disease Control and Prevention . Toxigenic Corynebacterium diphtheriae—Northern Plains Indian Community, August-October 1996. MMWR. 1998;46:506–510
  13. Centers for Disease Control and Prevention . Diphtheria, Tetanus and Pertussis. In: Health Information for International Travel 2003-2004. Atlanta, GA: US Department of Health and Human Services, Public Health Service; 2003;p. 59–63 Available at: http://www.cdc.gov/travel/diseases/dtp.htm. Accessed October 22, 2003.
  14. Centers for Disease Control and Prevention . Fatal respiratory diptheria in a US traveler to Haiti—Pennsylvania, 2003. MMWR. 2004;52:1285–1286
  15. McQuillan GM, Chu SY. Diphtheria and tetanus immunity [letter]. Ann Intern Med. 2002;137:775
  16. Alagappan K, Rennie W, Kwiatkowski T, et al.  Antibody protection to diphtheria in geriatric patients: need for ED compliance with immunization guidelines. Ann Emerg Med. 1997;30:455–458
  17. Vitek CR, Wharton M. Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg Infect Dis. 1998;4:539–550

☆ The author reports this study did not receive any outside funding or support.Reprints not available from the author.

PII: S0196-0644(03)01132-6

doi: 10.1016/j.annemergmed.2003.10.047

Annals of Emergency Medicine
Volume 43, Issue 3 , Pages 315-317 , March 2004

Article Tools